Literature DB >> 33746108

Ingenuity and resiliency of syringe service programs on the front lines of the opioid overdose and COVID-19 crises.

Lynn D Wenger1, Alex H Kral2, Ricky N Bluthenthal3, Terry Morris2, Lee Ongais2, Barrot H Lambdin2.   

Abstract

As COVID-19 accelerated throughout 2020, syringe service programs (SSPs) faced challenges necessitating programmatic adaptations to prevent overdose deaths while simultaneously keeping workers and participants safe from COVID-19. We used qualitative methods to gain an understanding of the social context within which SSPs are operating during the COVID-19 pandemic. We conducted 36 in-depth interviews with program representatives from 18 programs and used the Exploration, Preparation, Implementation, Sustainment (EPIS) implementation framework to guide data analysis. We focused on 3 of the 4 EPIS constructs: Outer context, inner context, and innovation factors. Our data indicate that responding to the pandemic led to innovations in service delivery such as secondary and mail-based distribution, adoption of telemedicine for enrolling participants in medications for opioid use disorder (MOUD) and use of virtual training platforms for overdose prevention. We found high levels of staff and volunteer commitment, which was a cornerstone to the success of these innovations. We observed that many SSPs were short-staffed because of their commitment to safety, and some lost current funding as well as opportunities for future funding. Despite minimal staffing and diminished funding, SSPs innovated at an accelerated pace. To ensure the sustainability of these new approaches, a supportive external context (federal, state, and local policies and funding) is needed to support the development of SSPs' inner contexts (organizational characteristics, characteristics of individuals) and sustainment of the innovations achieved regarding delivery of naloxone and MOUD.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CDC = U.S. Centers for Disease Control and Prevention; COVID-19 = Novel coronavirus 2019; EPIS = Exploration, Preparation, Implementation, and Sustainment implementation framework; HCV = hepatitis C virus; MOUD = medications for opioid use disorder; OENDα = overdose education and naloxone distribution; PWUD = people who use drugs; SSP = syringe service program

Year:  2021        PMID: 33746108     DOI: 10.1016/j.trsl.2021.03.011

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  11 in total

1.  "We were building the plane as we were flying it, and we somehow made it to the other end": syringe service program staff experiences and well-being during the COVID-19 pandemic.

Authors:  Andrea Wang; Raagini Jawa; Sarah Mackin; Liz Whynott; Connor Buchholz; Ellen Childs; Angela R Bazzi
Journal:  Harm Reduct J       Date:  2022-07-15

2.  A comparison of the COVID-19 response for urban underserved patients experiencing healthcare transitions in three Canadian cities.

Authors:  Ginetta Salvalaggio; Elaine Hyshka; Cara Brown; Andrew D Pinto; Gayle Halas; Lee Green; Brynn Kosteniuk; Melissa Perri; Nathaniel Le Chalifoux; Garrett Halas; Liane Steiner; Teresa Cavett; Stephanie Montesanti
Journal:  Can J Public Health       Date:  2022-06-30

3.  Naloxone administration among opioid-involved overdose deaths in 38 United States jurisdictions in the State Unintentional Drug Overdose Reporting System, 2019.

Authors:  Kelly Quinn; Sagar Kumar; Calli T Hunter; Julie O'Donnell; Nicole L Davis
Journal:  Drug Alcohol Depend       Date:  2022-04-16       Impact factor: 4.852

4.  Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky.

Authors:  Jennifer L Glick; Suzanne M Grieb; Samantha J Harris; Brian W Weir; Katherine C Smith; Tyler Puryear; Rebecca Hamilton White; Sean T Allen
Journal:  Harm Reduct J       Date:  2022-05-19

5.  The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months.

Authors:  Alex S Bennett; Tarlise Townsend; Luther Elliott
Journal:  Int J Drug Policy       Date:  2021-12-01

6.  PrEP Care Continuum Engagement Among Persons Who Inject Drugs: Rural and Urban Differences in Stigma and Social Infrastructure.

Authors:  Suzan M Walters; David Frank; Brent Van Ham; Jessica Jaiswal; Brandon Muncan; Valerie Earnshaw; John Schneider; Samuel R Friedman; Danielle C Ompad
Journal:  AIDS Behav       Date:  2021-10-09

7.  The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.

Authors:  Kinna Thakarar; Michael Kohut; Rebecca Hutchinson; Rebecca Bell; Hannah E Loeb; Debra Burris; Kathleen M Fairfield
Journal:  Harm Reduct J       Date:  2022-07-22

8.  "We figured it out as we went along": Staff perspectives of COVID-19 response efforts at a large North American syringe services programme.

Authors:  Patrick J A Kelly; Jenine Pilla; AnnaMarie Otor; Ariel Hoadley; Sarah Bauerle Bass
Journal:  Health Soc Care Community       Date:  2022-06-14

9.  Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S.

Authors:  Madeline C Frost; Elsa W Sweek; Elizabeth J Austin; Maria A Corcorran; Alexa M Juarez; Noah D Frank; Stephanie M Prohaska; Paul A LaKosky; Alice K Asher; Dita Broz; Don C Des Jarlais; Emily C Williams; Sara N Glick
Journal:  AIDS Behav       Date:  2021-06-10

10.  "We have to be uncomfortable and creative": Reflections on the impacts of the COVID-19 pandemic on overdose prevention, harm reduction & homelessness advocacy in Philadelphia.

Authors:  Shoshana V Aronowitz; Eden Engel-Rebitzer; Margaret Lowenstein; Zachary Meisel; Evan Anderson; Eugenia South
Journal:  SSM Qual Res Health       Date:  2021-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.